Methods for therapy for solid tumors expressing the CD40 cell surface antigen
Номер патента: DK1680141T3
Опубликовано: 01-11-2010
Автор(ы): Asha Yabannavar, Isabel Zaror, Li Long, Mohammad Luqman
Принадлежит: Novartis Vaccines & Diagnostic, Xoma Technology Ltd
Опубликовано: 01-11-2010
Автор(ы): Asha Yabannavar, Isabel Zaror, Li Long, Mohammad Luqman
Принадлежит: Novartis Vaccines & Diagnostic, Xoma Technology Ltd
Mesothelin-targeted CD40 agonistic multispecific antibody constructs for the treatment of solid tumors
Номер патента: US11926672B2. Автор: Xin Yu,Jackson EGEN,Shunsuke Takenaka,Fernando Garces,AeRyon KIM,Deepali Sawant. Владелец: AMGEN INC. Дата публикации: 2024-03-12.